
About Evrys Bio
Evrys Bio is a Healthcare company based in Doylestown (United States). Evrys Bio is focused on developing broad-spectrum antiviral therapies. It operates on a HealthTech model. Evrys Bio offers products and services including SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral. Its focus areas include Biotechnology and Antiviral Therapeutics.
Company details
Evrys Bio is engaged in the development of next-generation antiviral therapeutics targeting human sirtuin proteins to enhance natural immunity against viral infections. The company operates in the biotechnology sector, addressing unmet medical needs in infectious diseases. Solutions are designed to combat multiple viruses simultaneously, including hepatitis, respiratory infections, and opportunistic infections in immunosuppressed patients. Their innovative approach aims to overcome drug resistance by leveraging the patients own cellular mechanisms, transforming the treatment landscape for viral diseases with broad-spectrum antiviral products.
- Headquarters Doylestown, United States
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website forgelifescience.com
Products & Services of Evrys Bio
Evrys Bio offers a comprehensive portfolio of products and services, including SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral.
Broad-spectrum antiviral targeting sirtuins to combat viral infections.
Antiviral addressing respiratory infections including coronaviruses and influenza.
Antiviral targeting hepatitis B, C, D, and E viruses.
People of Evrys Bio
39 people are tracked at Evrys Bio (10 in leadership, 24 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Matthew Todd | Head, Enzymology & Biophysics | Leadership |
Lillian W. Chiang | President & CEO | Leadership |
Susan Little | Head, Human Resources | Leadership |
Dana M Fowlkes | Chief Business Officer | Leadership |
Stacy W. Remiszewski | VP, Research | Leadership |
John L. Kulp III | Director, Business Development | Leadership |
Steven Ma | Director, Operations | Leadership |
Steven Ma Ph.D. | Director Of Operations | Leadership |
John Kulp | Director Of Business Development | Leadership |
Jens Knudsen | Chief Financial Officer | Leadership |
Debra Yu | Advisor | Board & advisors |
Richard J. Whitley | Clinical Advisor | Board & advisors |
Paul Griffiths | Clinical Advisor | Board & advisors |
David Thomas | Clinical Advisor | Board & advisors |
Camille Kotton | Clinical Advisor | Board & advisors |
Michael Boeckh | Clinical Advisor | Board & advisors |
Alan Goldberg | Scientific Advisor | Board & advisors |
Bruce Maryanoff | Scientific Advisor | Board & advisors |
Eric Hanson | Scientific Advisor | Board & advisors |
Tage Honoré | Scientific Advisor | Board & advisors |
19 more people are available in the full profile.
Complete people profiles for Evrys Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as Evrys Bio (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evrys Bio
Evrys Bio is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.
Evrys Bio is engaged in the development of next-generation antiviral therapeutics targeting human sirtuin proteins to enhance natural immunity against viral infections. The company operates in the biotechnology sector, addressing unmet medical needs in infectious diseases. Solutions are designed to combat multiple viruses simultaneously, including hepatitis, respiratory infections, and opportunistic infections in immunosuppressed patients. Their innovative approach aims to overcome drug resistance by leveraging the patients own cellular mechanisms, transforming the treatment landscape for viral diseases with broad-spectrum antiviral products.
Evrys Bio offers SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral.